- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07940205
Machine-learning Algorithm for Prediction of CKD From Retinal Images (healthy route)
A Validation Study to Assess Performance Accuracy of a Machine-Learning Algorithm for the Prediction of Chronic Kidney Disease (CKD) From Digital Retinal Images
This is a non-interventional study being conducted to validate the performance of a machine learning algorithm for prediction of eGFR from digital retinal images in a target population for future intended use as a populated-based screening tool. Secondary objectives will include prediction of blood pressure (> or ≤ 140/90 mmHg) and presence or absence of T2DM as determined by glycated haemoglobin (HbA1c >6.5%) or on the basis of clinical history. Once validated, the methodology will be deployed for health screening to improve access to healthcare.
Studieöversikt
Status
Intervention / Behandling
Studietyp
Inskrivning (Beräknad)
Kontakter och platser
Studiekontakt
- Namn: Mohamed Khalis, Professor
- Telefonnummer: +212 628-245023
- E-post: mkhalis@um6ss.ma
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
The study population consists of adult patients diagnosed with chronic kidney disease (CKD), hypertension, diabetes mellitus, or without these conditions, attending routine outpatient clinics at Hôpital Universitaire International Cheikh Khalifa Ibn Zaid in Casablanca and Centre Hospitalier Universitaire Hassan II in Fez, Morocco.
Beskrivning
Inclusion Criteria
Participants are eligible to be included in the study only if all of the following criteria apply:
- Participant must be ≥ 18 years of age, at the time of signing the informed consent.
- Previously documented eGFR ≥ 3months
- Any participant with a positive dipstick result for proteinuria of at least trace
- Capable of giving signed informed consent as described in Appendix A which includes compliance with the requirements and restrictions listed in the informed consent form and in this protocol
Exclusion Criteria:
-
Participants are excluded from the study if any of the following criteria apply:
- As judged by the investigator, any evidence of a condition which in the investigator's opinion makes it undesirable for the participant to participate in the study.
- Any known eye condition that may preclude clear imaging of the retina for example; cataracts
- Individuals with hypertensive emergencies and hyperglycemic or hypoglycemic emergencies
- Involvement in the planning and/or conduct of the study (applies to HHA/ AstraZeneca staff and/or staff at the study site).
- Judgment by the investigator that the participant should not participate in the study if the participant is unlikely to comply with study procedures, restrictions and requirements.
Studieplan
Hur är studien utformad?
Designdetaljer
- Observationsmodeller: CASE_CONTROL
- Tidsperspektiv: CROSS_SECTIONAL
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
CKD Cases
350 participants (cases) with diabetes and/or hypertension and/or CKD with previously documented eGFR < 60 ml/min/1.73m2 ≥3 months |
A machine learning-based algorithm analyzes retinal images to assess its ability to detect chronic kidney disease |
|
Controls
150 (controls) with previously documented eGFR ≥ 60 ml/min/1.73m2 ≥ 3 months |
A machine learning-based algorithm analyzes retinal images to assess its ability to detect chronic kidney disease |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
The accuracy of a machine-learning based algorithm to predict high risk CKD from digital retinal images
Tidsram: Baseline
|
To quantify the discrimination of the machine-learning algorithm for identifying the binary target condition of persistent eGFR <60 mL/min/1.73 m², using standard-of-care serum creatinine as the reference standard and the AUROC with a 95% confidence interval as the primary performance measure |
Baseline
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Accuracy of the Machine Learning Algorithm for Detection of Hypertension and T2DM
Tidsram: Baseline
|
To quantify the sensitivity, specificity, and discriminative performance of a machine-learning-based algorithm for identifying SBP >140 mmHg from digital retinal images, using standard-of-care assessment as the reference standard and the AUROC with a 95% confidence interval as the primary performance measure |
Baseline
|
Samarbetspartners och utredare
Samarbetspartners
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
- Urogenitala sjukdomar
- Sjukdomar i det endokrina systemet
- Kärlsjukdomar
- Hjärt-kärlsjukdomar
- Patologiska processer
- Manliga urogenitala sjukdomar
- Njursjukdomar
- Urologiska sjukdomar
- Kvinnliga urogenitala sjukdomar
- Kvinnliga urogenitala sjukdomar och graviditetskomplikationer
- Kronisk sjukdom
- Sjukdomsegenskaper
- Metaboliska sjukdomar
- Störningar i glukosmetabolism
- Diabetes mellitus
- Njurinsufficiens
- Patologiska tillstånd, tecken och symtom
- Närings- och metabola sjukdomar
- Hypertoni
- Diabetes mellitus, typ 2
- Njurinsufficiens, kronisk
Andra studie-ID-nummer
- CKD-AI-2026-07
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .